These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7737937)

  • 21. Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors.
    Flanagan P; McAlpine L; Ramskill SJ; Smith AG; Eglin R; Parry JV; Mortimer PP
    Vox Sang; 1995; 68(4):220-4. PubMed ID: 7660640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS: proposed WHO criteria for interpreting western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II.
    Bull World Health Organ; 1991; 69(1):127-9, 131-3. PubMed ID: 2054916
    [No Abstract]   [Full Text] [Related]  

  • 23. Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Dec; 39(50):915, 921-4. PubMed ID: 1979140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.
    Coste J; Lemaire JM; Couroucé AM; Canavaggio M
    AIDS; 1993 Mar; 7(3):440-1. PubMed ID: 8097098
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of triple retroviral infection with HIV-1 (genotype C3), HIV-2 and HTLV-I.
    Ramalingam S; Kannangai R; Prakash KJ; Jesudason MV; Sridharan G
    Natl Med J India; 2000; 13(5):274-5. PubMed ID: 11190060
    [No Abstract]   [Full Text] [Related]  

  • 26. Seroprevalence and risk factors associated with HTLV-I/II infection in injection drug users in northern New Jersey.
    Freeman RC; Rodriguez GM; French JF
    J Addict Dis; 1995; 14(3):51-66. PubMed ID: 8555279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
    Cooke FJ; Geretti AM; Zuckerman M
    J Med Virol; 2005 Jun; 76(2):143-5. PubMed ID: 15834880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current aspects of HIV infection].
    Gürtler LG
    Beitr Infusionsther; 1991; 28():1-6. PubMed ID: 1725606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
    Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
    J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population.
    Tseliou PM; Spiliotakara A; Politis C; Spanakis N; Legakis NJ; Tsakris A
    Transfus Med; 2004 Jun; 14(3):253-4. PubMed ID: 15180821
    [No Abstract]   [Full Text] [Related]  

  • 32. [The significance of HTLV-1 and HIV-2 for transfusion medicine in Europe].
    Gürtler L
    Beitr Infusionsther; 1989; 24():27-32. PubMed ID: 2481545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
    Olaleye OD; Ekweozor CC
    Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.
    Toro C; Soriano V; Tuset C; Aguilera A; Caballero E; de Lejarazu RO; Rodés B;
    HIV Clin Trials; 2002; 3(5):397-402. PubMed ID: 12407489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update: HIV-2 infection among blood and plasma donors--United States, June 1992-June 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Aug; 44(32):603-6. PubMed ID: 7630339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
    de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
    Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A serosurvey of hepatitis B virus, hepatitis C virus, human T lymphotropic virus type-1 and syphilis in HIV-1-infected patients in Jamaica.
    Smikle MF; Heslop O; Vickers I; Dowe G; Deer D; Sue-Ho R; Denbow CE; St C Morgan O; Bain B; Barton EN
    West Indian Med J; 2003 Mar; 52(1):14-7. PubMed ID: 12806748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.